Arcus Biosciences Inc (RCUS) - News Archive

Arcus Biosciences Boosts Cancer Therapies Development by Offering Stock Option Grants to New EmployeesHAYWARD, Calif. - Arcus Biosciences, a leading clinical-stage biopharmaceutical company focused on developing innovat...

In the continuous odyssey of medical research, a glimmer of hope emerges as new findings on Quemliclustat-based regimens show encouraging overall survival data in patients with untreated metastatic pancreatic ductal ade...

Exelixis and Arcus Biosciences Collaborate in Groundbreaking Trial to Combat Advanced Renal Cell CarcinomaALAMEDA, Calif. & HAYWARD, Calif. - Biopharmaceutical giants Exelixis, Inc. (Nasdaq: EXEL) and Arcus Biosciences...

Investigative Arcus Biosciences Grants Stock Options to New Employees to Attract Top TalentHayward, Calif. - Arcus Biosciences, a clinical-stage biopharmaceutical company dedicated to developing innovative cancer treatm...

Arcus Biosciences, a leading global biopharmaceutical company specializing in the development of innovative cancer treatments, has recently announced the grant of stock options to eight new employees. These options have...